Armistice Capital’s Colgate-Palmolive CL Stock Holding History

Armistice Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,259	Closed	-$384K	–	281
2024 Q1	$384K	Sell	4,259 -535,204	-99%	-$45.3M	0.01%	222
2023 Q4	$43M	Sell	539,463 -422,537	-44%	-$31.8M	0.59%	31
2023 Q3	$68.4M	Buy	962,000 +361,000	+60%	+$27M	1.05%	10
2023 Q2	$46.3M	Sell	601,000 -345,000	-36%	-$26.7M	0.67%	27
2023 Q1	$71.1M	Buy	946,000 +845,000	+837%	+$62.8M	1.02%	22
2022 Q4	$7.96M	Sell	101,000 -214,000	-68%	-$16M	0.14%	82
2022 Q3	$22.1M	Sell	315,000 -157,000	-33%	-$12.3M	0.38%	55
2022 Q2	$37.8K	Sell	472,000 -164,000	-26%	-$12.8M	0.66%	40
2022 Q1	$48.2M	Buy	636,000 +368,000	+137%	+$29.1M	0.93%	31
2021 Q4	$22.9M	Sell	268,000 -4,000	-1%	-$312K	0.37%	58
2021 Q3	$20.6M	Buy	272,000 +36,000	+15%	+$2.86M	0.35%	69
2021 Q2	$19.2M	Hold	236,000	–	–	0.34%	71
2021 Q1	$18.6M	Buy	+236,000	New	+$18.5M	0.43%	58
2020 Q4	–	Sell	-300,000	Closed	-$23.1M	–	109
2020 Q3	$23.1M	Sell	300,000 -68,000	-18%	-$5.18M	0.84%	45
2020 Q2	$27M	Buy	368,000 +188,000	+104%	+$13.4M	1.18%	34
2020 Q1	$11.9M	Buy	+180,000	New	+$12.7M	0.74%	46

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Armistice Capital's CL Position: Q2 2024 in Review

Armistice Capital sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 4,259 shares — an estimated $384K sold.

Armistice Capital first reported a position in CL in Q1 2020 and held it in 16 quarters. The position peaked at $71.1M in Q1 2023. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.

Armistice Capital reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
Armistice Capital sold 4,259 Colgate-Palmolive shares in Q2 2024, an estimated $384K.
Armistice Capital first reported a position in Colgate-Palmolive in Q1 2020 and held it in 16 quarters.
Armistice Capital's Colgate-Palmolive position peaked at $71.1M in Q1 2023.
1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.